MedPath

Dalfampridine in improving spasticity in patients with severe brain trauma

Phase 3
Recruiting
Conditions
Severe traumatic brain injury.
Diffuse traumatic brain injury
S06.2
Registration Number
IRCT20221108056446N2
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Being between 18 and 65 years old
More than a month has passed since the beginning of the trauma
Having a level of consciousness less than 9
Not having a neurological or psychological disease before the trauma
Presence of spasticity in the upper or lower limbs according to the Ashworth criteria

Exclusion Criteria

Lack of consent of the patient's companion to enter the study
Having a level of consciousness higher than 9 at the beginning of the trauma
History of seizures, kidney and liver diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of muscle spasms. Timepoint: Before treatment, three and six months after the intervention. Method of measurement: Ashworth scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath